50 results on '"Fogelman I"'
Search Results
2. Precision of 18F-fluoride PET skeletal kinetic studies in the assessment of bone metabolism
3. Regional bone metabolism at the lumbar spine and hip following discontinuation of alendronate and risedronate treatment in postmenopausal women
4. Circulating Sclerostin and Dickkopf-1 (DKK1) in Predialysis Chronic Kidney Disease (CKD): Relationship with Bone Density and Arterial Stiffness
5. ‘Sink or swim’: an evaluation of the clinical characteristics of individuals with high bone mass
6. The effect of weight and weight change on the long-term precision of spine and hip DXA measurements
7. Circulating Fibroblast Growth Factor-23 Increases Following Intermittent Parathyroid Hormone (1–34) in Postmenopausal Osteoporosis: Association with Biomarker of Bone Formation
8. Fibroblast growth factor-23 is associated with C-reactive protein, serum phosphate and bone mineral density in chronic kidney disease
9. Significant differences in UK and US female bone density reference ranges
10. Parathyroid Hormone(1–84) Treatment of Postmenopausal Women with Low Bone Mass Receiving Hormone Replacement Therapy
11. Peripheral and Central Measurements of Bone Mineral Density Are Equally Strongly Associated with Clinical Risk Factors for Osteoporosis
12. Predicting the Risk of Fracture at Any Site in the Skeleton: Are All Bone Mineral Density Measurement Sites Equally Effective?
13. Dual X-ray Absorptiometry: Clinical Evaluation of a New Cone-Beam System
14. Abstracts of original contributions ASNC 2004 9th annual scientific session September 3-–October 3, 2004 New York, New York
15. Can the WHO definition of osteoporosis be applied to multi-site axial transmission quantitative ultrasound?
16. Periprosthetic bone remodelling of two types of uncemented femoral implant with proximal hydroxyapatite coating: a 3-year follow-up study addressing the influence of prosthesis design and preoperative bone density on periprosthetic bone loss
17. Bone mineral density in premenopausal women treated for node-positive early breast cancer with 2 years of goserelin or 6 months of cyclophosphamide, methotrexate and 5-fluorouracil (CMF)
18. Differential effects of hormone replacement therapy on bone mineral density and axial transmission ultrasound measurements in cortical bone
19. A comparison of fracture discrimination using calcaneal quantitative ultrasound and dual X-ray absorptiometry in women with a history of fracture at sites other than the spine and hip
20. Multisite Quantitative Ultrasound: Colles’ Fracture Discrimination in Postmenopausal Women
21. COLIA1 Sp1 Polymorphism Predicts Response of Femoral Neck Bone Density to Cyclical Etidronate Therapy
22. Changes in QUS and BMD Measurements with Antiresorptive Therapy: A Two-Year Longitudinal Study
23. Cyclical Etidronate Therapy for Prevention of Postmenopausal Bone Loss: A 1-Year Open-Label Follow-Up Study
24. Optimizing data acquisition and analysis of morphometric X-ray absorptiometry
25. Vitamin D and bone mineral density
26. The Effect of Weight Change on DXA Scans in a 2-Year Trial of Etidronate Therapy
27. A longitudinal study of supine lateral DXA of the lumbar spine: A comparison with posteroanterior spine, hip and total-body DXA
28. The accuracy of volumetric bone density measurements in dual X-ray absorptiometry
29. Effect of tibolone on postmenopausal bone loss
30. Clinical experience with etidronate in osteoporosis
31. Distribution of bone mineral density in the lumbar spine in health and osteoporosis
32. Fractal signature analysis of macroradiographs measures trabecular organization in lumbar vertebrae of postmenopausal women
33. Patient dose in dual x-ray absorptiometry
34. Measurements of postmenopausal bone loss with a new contact ultrasound system
35. Bone single-photon emission tomography in recent meniscal tears: an assessment of diagnostic criteria
36. Spine and femur BMD by DXA in patients with varying severity spinal osteoporosis
37. Comparison of simultaneous 99mTc-HMPAO and 111In oxine labelled white cell scans in the assessment of inflammatory bowel disease
38. Ultrasonic velocity measurements through the calcaneus: Which velocity should be measured?
39. Measurements of broadband ultrasonic attenuation in the calcaneus in premenopausal and postmenopausal women
40. Bisphosphonates and vertebral fracture: An epidemiological perspective
41. Recent advances in bone densitometry
42. Strontium does accumulate in bone
43. Reply
44. Tibolone, a form of HRT without the need for withdrawal bleeding prevents postmenopaubal bone loss (4 years follow-UP)
45. Caclaneal bua changes in a 2 year placebo controlled study of pamidronate in post menopausal osteoporosis
46. Effect of etidronate disodium on bone turnover following surgical menopause
47. Diphosphonates in the evaluation of metabolic bone disease
48. Successful localisation of parathyroid adenomata by thallium-201 and technetium-99m subtraction scintigraphy: description of an improved technique
49. Comparison of the pharmacokinetics of 14C-labelled APD and 99m Tc-labelled APD in the mouse
50. Metabolic disturbances identified by SPECT-CT in patients with a clinical diagnosis of sacroiliac joint incompetence.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.